Literature DB >> 21870078

Clinicopathological findings of immunoglobulin G4-related kidney disease.

Shinichi Nishi1, Naofumi Imai, Kazuhiro Yoshida, Yumi Ito, Takako Saeki.   

Abstract

Immunoglobulin (Ig) G4-related kidney disease characterizing tubulointerstitial nephritis (TIN) is an organ complication recognized in IgG4-related systemic diseases that has some unique aspects compared to other types of TIN. TIN lesions in the kidney can be tumor-like, focal or diffuse. Abnormal urinalysis is usually mild or absent even in the cases with deteriorated renal dysfunction. Some cases are accidentally diagnosed from radiological findings without renal dysfunction and/or abnormal urinalysis. The typical pathological findings of TIN are unique fibrosis and infiltration of massive lymphocytes and IgG4-positive plasma cells. Glomerular lesions are rare but the complication of mesangial proliferative glomerulonephritis and membranous nephropathy is occasionally reported. Pathogenic mechanisms are unclear until now; however, auto-immune and allergic mechanisms have been suspected from laboratory data. The initial response to steroid agents is generally favorable; however, recurrence is possible after the discontinuation of steroid treatment. Long-term follow-up is necessary with continuous systemic checks for organ disorders due to IgG4-related systemic diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870078     DOI: 10.1007/s10157-011-0526-x

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  58 in total

Review 1.  IgG4-related chronic tubulointerstitial nephritis without autoimmune pancreatitis and the time course of renal function.

Authors:  Yutaka Tsubata; Fumihiro Akiyama; Takeshi Oya; Junya Ajiro; Takako Saeki; Shinichi Nishi; Ichiei Narita
Journal:  Intern Med       Date:  2010-08-02       Impact factor: 1.271

2.  A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4.

Authors:  Asuka Aoki; Keitaro Sato; Mitsuyo Itabashi; Takashi Takei; Takumi Yoshida; Junko Arai; Keiko Uchida; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2009-01-14       Impact factor: 2.801

3.  Successful treatment of sclerosing mediastinitis with a high serum IgG4 level.

Authors:  Masaaki Inoue; Naohiro Nose; Hitoshi Nishikawa; Masaaki Takahashi; Yoh Zen; Makoto Kawaguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-10

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency.

Authors:  J S van der Zee; P van Swieten; R C Aalberse
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

6.  Autoimmune cholangitis associated to IgG4 related sclerosing disease.

Authors:  Bernardo Frider; Andrés Bruno; Marcelo Zylberman; Alejandro Oría; Marcelo Amante
Journal:  Acta Gastroenterol Latinoam       Date:  2011-03

7.  Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours.

Authors:  Lucas Rudmik; Kiril Trpkov; Carla Nash; Susan Kinnear; Vincent Falck; John Dushinski; Elijah Dixon
Journal:  CMAJ       Date:  2006-08-15       Impact factor: 8.262

8.  Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4.

Authors:  Yoh Zen; Manabu Onodera; Dai Inoue; Azusa Kitao; Osamu Matsui; Takahiro Nohara; Mikio Namiki; Satomi Kasashima; Atsuhiro Kawashima; Yasushi Matsumoto; Kazuyoshi Katayanagi; Tetsuya Murata; Shin Ishizawa; Noriko Hosaka; Ken Kuriki; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

9.  Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer.

Authors:  Tae Yoon Lee; Myung-Hwan Kim; Do Hyun Park; Dong Wan Seo; Sung Koo Lee; Jae Seung Kim; Kyu Taek Lee
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

10.  Tubulointerstitial nephritis associated with IgG4-related systemic disease.

Authors:  Takako Saeki; Akihiko Saito; Hajime Yamazaki; Iwao Emura; Naofumi Imai; Mitsuhiro Ueno; Shinichi Nishi; Syoji Miyamura; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

View more
  21 in total

1.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.

Authors:  John H Stone; Arezou Khosroshahi; Vikram Deshpande; John K C Chan; J Godfrey Heathcote; Rob Aalberse; Atsushi Azumi; Donald B Bloch; William R Brugge; Mollie N Carruthers; Wah Cheuk; Lynn Cornell; Carlos Fernandez-Del Castillo; Judith A Ferry; David Forcione; Günter Klöppel; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Yasufumi Masaki; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant Sahani; Yasuharu Sato; Thomas Smyrk; James R Stone; Masayuki Takahira; Hisanori Umehara; George Webster; Motohisa Yamamoto; Eunhee Yi; Tadashi Yoshino; Giuseppe Zamboni; Yoh Zen; Suresh Chari
Journal:  Arthritis Rheum       Date:  2012-10

Review 2.  IgG4-related renal disease: clinical and pathological characteristics.

Authors:  Naoto Kuroda; Tomoya Nao; Hideo Fukuhara; Takashi Karashima; Keiji Inoue; Yoshinori Taniguchi; Mai Takeuchi; Yoh Zen; Yasuharu Sato; Kenji Notohara; Tadashi Yoshino
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Tubulointerstitial fibrosis in patients with IgG4-related kidney disease: pathological findings on repeat renal biopsy.

Authors:  Haruna Arai; Hiroki Hayashi; Kazuo Takahashi; Shigehisa Koide; Waichi Sato; Midori Hasegawa; Yutaka Yamaguchi; Jan Aten; Yasuhiko Ito; Yukio Yuzawa
Journal:  Rheumatol Int       Date:  2014-11-05       Impact factor: 2.631

4.  IgG4-related tubulointerstitial nephritis associated with only lymphadenopathy and without elevated serum IgG4 or renal imaging abnormalities: a case report and literature review.

Authors:  Xi Qiao; Lihua Wang; Chen Wang; Lifang Gao; Shulei Yao; Liran Wu; Xiaoqin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis.

Authors:  Ichiro Mizushima; Kazunori Yamada; Hiroshi Fujii; Dai Inoue; Hisanori Umehara; Masakazu Yamagishi; Yutaka Yamaguchi; Michio Nagata; Masami Matsumura; Mitsuhiro Kawano
Journal:  Mod Rheumatol       Date:  2012-01-20       Impact factor: 3.023

6.  IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor.

Authors:  Arezou Khosroshahi; Rivka Ayalon; Laurence H Beck; David J Salant; Donald B Bloch; John H Stone
Journal:  Int J Rheumatol       Date:  2012-05-10

7.  Evaluation of diagnostic criteria for IgG4-related tubulointerstitial nephritis.

Authors:  Xuanli Tang; Bin Zhu; Riping Chen; Yunqin Hu; Yinghua Zhang; Xiaoling Zhu; Hongyu Chen; Yongjun Wang
Journal:  Diagn Pathol       Date:  2015-07-01       Impact factor: 2.644

8.  An Overlapping Case of Lupus Nephritis and IgG4-Related Kidney Disease.

Authors:  Mazen Zaarour; Chanudi Weerasinghe; Ahmad Eter; Suzanne El-Sayegh; Elie El-Charabaty
Journal:  J Clin Med Res       Date:  2015-05-08

9.  Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy.

Authors:  Yoko Wada; Takako Saeki; Kazuhiro Yoshita; Rivka Ayalon; Kenya Kamimura; Masaaki Nakano; Ichiei Narita
Journal:  Clin Kidney J       Date:  2013-08-13

10.  Membranoproliferative glomerulonephritis with predominant IgG2 and IgG3 deposition in a patient with IgG4-related disease.

Authors:  Kenji Ueki; Yuta Matsukuma; Kosuke Masutani; Akihiro Tsuchimoto; Kiichiro Fujisaki; Kumiko Torisu; Shigeru Tanaka; Tamotsu Kiyoshima; Satoshi Hisano; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  BMC Nephrol       Date:  2015-10-26       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.